Fentanyl Buccal Tablet

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2006-2018
024620062018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
OBJECTIVES The aim of this study was to compare the efficacy and safety of doses of fentanyl buccal tablet (FBT) proportional to… (More)
Is this relevant?
2009
2009
BACKGROUND This study assessed the long-term safety and tolerability of fentanyl buccal tablet (FBT) in opioid-tolerant patients… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2008
Review
2008
Studies of populations with chronic cancer pain have shown a high prevalence of breakthrough pain (BTP), defined as transitory… (More)
Is this relevant?
2008
2008
BACKGROUND AND OBJECTIVE The fentanyl buccal tablet (FBT) is formulated to enhance the rate and extent of fentanyl absorption… (More)
Is this relevant?
2007
2007
This study assessed the absolute and relative bioavailabilities and transmucosal and gastrointestinal absorbency of fentanyl… (More)
Is this relevant?
2007
2007
BACKGROUND Short-acting opioids are commonly used to treat breakthrough pain (BTP) and rapid-onset formulations are being… (More)
Is this relevant?
2007
2007
Fentanyl buccal tablet (FBT) is a new opioid formulation providing rapid-onset analgesia for the treatment of breakthrough pain… (More)
Is this relevant?
2007
2007
BACKGROUND AND OBJECTIVES Patients with cancer, particularly those undergoing chemotherapy or radiotherapy, may develop oral… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
OBJECTIVES Cancer-related breakthrough pain (BTP) is typically managed with a short-acting oral opioid, taken as needed during a… (More)
Is this relevant?
2006
2006
BACKGROUND The fentanyl buccal tablet (FBT) is designed to enhance the rate and extent of fentanyl absorption through the buccal… (More)
Is this relevant?